Generic Name RANIBIZUMAB-EQRN Review Date Began Mon, 09/26/2022 - 12:00 Review Date Completed Thu, 11/10/2022 - 12:00 Conclusion PDL Product Committee Month Thu, 12/01/2022 - 12:00 Sun, 01/01/2023 - 12:00